Reticulon 3 attenuates the clearance of cytosolic prion aggregates by inhibiting autophagy
Reticulon 3 attenuates the clearance of cytosolic prion aggregates by inhibiting autophagy
复制标题
Reticulon 3 通过抑制自噬来减弱胞质朊病毒聚集体的清除
DOI:
10.4161/auto.7.2.14197
复制
发表时间:
2011-02-01
期刊:
影响因子:
13.3
通讯作者:
Xiao, Gengfu
中科院分区:
文献类型:
--
作者:
Chen, Rui;Jin, Rui;Xiao, Gengfu
Autophagy plays an important role in targeting cellular proteins, protein aggregates and organelles for degradation for cell survival. Autophagy dysfunction has been extensively described in neurodegenerative conditions linked to protein misfolding and aggregation. However, the role of autophagy in the prion disease process is unclear. Here, we show that when expressed in mouse neuroblastoma N2a cells, cytoplasmic PrP (cyPrP) aggregates lead to endoplasmic reticulum stress (ER stress), activation of reticulon 3 (RTN3), impairment of ubiquitin-proteasome system (UPS), induction of autophagy and apoptosis. RTN3 belongs to the reticulon family with the highest expression in the brain and RTN3 is often activated under ER stress. To assess the function of RTN3 in pathological conditions involving cyPrP protein misfolding, we knocked down the expression of RTN3 in cyPrP-transfected cells; unexpectedly, the inhibition of expression of RTN3 enhances the induction of autophagy resulted from cyPrP aggregates, and the process is mediated by the enhanced interaction between Bcl-2 and Beclin 1 promoted by RTN3, which enhances Bcl-2-mediated inhibition of Beclin 1-dependent autophagy. Furthermore, downregulation of RTN3 promoted the clearance of cyPrP aggregates, allowed the activity of the UPS to resume, and alleviated ER stress; ultimately, apoptosis due to the cyPrP aggregates was inhibited. Together, these data suggest that RTN3 negatively regulates autophagy to block the clearance of cyPrP aggregates and provide a clue regarding the potential to induce autophagy for the treatment of prion disease and other neurodegenerative diseases such as Parkinson disease (PD), Alzheimer disease (AD) and Huntington disease (HD).